| Prev Close | 200.73 |
| Day Low/High | 198.78 / 204.78 |
| 52 Wk Low/High | 94.26 / 200.93 |
United Therapeutics Corporation (UTHR)
203.36
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 44.54B |
| Market Cap | 8.94B |
| P/E Ratio | 15.87 |
| Div & Yield | N.A. (N.A) |
Latest News
United Therapeutics Gets a Quantitative Upgrade
Shares look to break out from long basing pattern.
United Therapeutics Has Room to Fall Farther
With the weekly close under the $120 support level, the next chart support lies around $90 -- the lows of 2014.
Why I'm Looking at Biotechs, Not Airlines
Cutthroat competition is good for customers, but not shareholders.
Jump on a Short Squeeze
These four stocks are all great candidates for this strategy.
Hunting for Straddle Plays
Low volatility ahead of a long weekend creates good conditions.
Pluristem CEO Seeing the Future in 3D Cells
Pluristem's successful stem cell trial last week on muscle injuries is an important first step for the company, says the company's CEO Zami Aberman.
Rules of the Game: Biotechs in Rally Mode
Here are two quality names in the sector to watch for a pullback.
A Famed Investor's Small-Cap Picks
Here are some less-followed names in Joel Greenblatt's portfolio.
The Next Big Thing In Biotech: Decision Week
Ziopharm, AP Pharma and Biogen Idec will headline a very big week of approval decisions, Adam Feuerstein, Sr. Columnist at TheStreet, tells Gregg Greenberg.
Joel Greenblatt's Top 'Magic Formula' Stocks
These three holdings offer consistent earnings growth and impressive returns on invested capital.
Seek Safety in Two Health Care Stocks
United Therapeutics and PharMerica have strong insider buying and should perform in a turbulent market.
